UBS Group’s 9 Meters Biopharma, Inc. Common Stock NMTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-4,340
Closed -$6.03K 8930
2023
Q1
$6.03K Sell
4,340
-7,989
-65% -$11.1K ﹤0.01% 6870
2022
Q4
$15.5K Buy
12,329
+6,584
+115% +$8.3K ﹤0.01% 6785
2022
Q3
$25K Sell
5,745
-1
-0% -$4 ﹤0.01% 6035
2022
Q2
$30K Buy
5,746
+4,314
+301% +$22.5K ﹤0.01% 5381
2022
Q1
$17K Sell
1,432
-4,456
-76% -$52.9K ﹤0.01% 6654
2021
Q4
$116K Buy
5,888
+2,733
+87% +$53.8K ﹤0.01% 5115
2021
Q3
$82K Buy
3,155
+240
+8% +$6.24K ﹤0.01% 4890
2021
Q2
$64K Buy
2,915
+1,139
+64% +$25K ﹤0.01% 5161
2021
Q1
$42K Sell
1,776
-1,978
-53% -$46.8K ﹤0.01% 5723
2020
Q4
$64K Buy
3,754
+3,694
+6,157% +$63K ﹤0.01% 4982
2020
Q3
$1K Buy
+60
New +$1K ﹤0.01% 6987
2020
Q2
Sell
-85
Closed -$1K 7416
2020
Q1
$1K Sell
85
-425
-83% -$5K ﹤0.01% 6912
2019
Q4
$6K Buy
+510
New +$6K ﹤0.01% 6470
2019
Q3
Sell
-3
Closed 7242
2019
Q2
$0 Buy
+3
New ﹤0.01% 7219
2019
Q1
Sell
-690
Closed -$32K 7223
2018
Q4
$32K Buy
690
+640
+1,280% +$29.7K ﹤0.01% 5540
2018
Q3
$7K Sell
50
-331
-87% -$46.3K ﹤0.01% 6433
2018
Q2
$179K Buy
+381
New +$179K ﹤0.01% 4183
2018
Q1
Sell
-68
Closed -$8K 7136
2017
Q4
$8K Buy
68
+12
+21% +$1.41K ﹤0.01% 6201
2017
Q3
$8K Buy
56
+10
+22% +$1.43K ﹤0.01% 6098
2017
Q2
$4K Buy
+46
New +$4K ﹤0.01% 6282
2017
Q1
Sell
-10
Closed -$3K 6900
2016
Q4
$3K Buy
+10
New +$3K ﹤0.01% 6454